chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient was anxious to get shot but seemed healthy otherwise. Shot was given at approximately at 1:40. By 1:45 she showed signs of being queasy and eventually passed out. Her father caught her, so no physical injuries were reported or seen. Blood pressure was taken roughly 3 minutes after collapse. In prone position on her back since loss of consciousness, her BP was 93/69 and pulse rate was 82.  Although ashen at first contact, her coloring was improving as EMS showed up 15 minutes after my arrival. Total incidence time was roughly 20 min.
Information has been received from a consumer concerning her sister, a female patient of unknown age. No relevant medical history or concurrent conditions were reported. On an unknown date the patient was vaccinated with ZOSTAVAX (lot#, expiration date, dose, frequency and route not reported). On an unknown date the patient developed shingles after getting the ZOSTAVAX. The outcome of the event was unknown. Causality assessment was not reported. Additional information is not expected as no contact details is available.
Information has been received from a health professional concerning a 7 year old male who was vaccinated with varicella virus vaccine live. Subsequently, the pt experienced vomiting. Unspecified medical attention was sought. No other information was provided. Additional information has been requested.
Arm soreness; Breaking out since 1st dose; Unresolved Small blisters; Unresolved Itch; This spontaneous case was reported by a consumer and describes the occurrence of BLISTER (Unresolved Small blisters), PRURITUS (Unresolved Itch), PAIN IN EXTREMITY (Arm soreness) and RASH (Breaking out since 1st dose) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003f21a, 04521a and 017b21a) for COVID-19 vaccination.     Concurrent medical conditions included Depression. Concomitant products included FLUOXETINE HYDROCHLORIDE (PROZAC) for Depression.   On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Mar-2021, the patient experienced BLISTER (Unresolved Small blisters), PRURITUS (Unresolved Itch) and RASH (Breaking out since 1st dose). On 22-Oct-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (Arm soreness). The patient was treated with MOMETASONE FUROATE at a dose of 1 dosage form. At the time of the report, BLISTER (Unresolved Small blisters), PRURITUS (Unresolved Itch) and RASH (Breaking out since 1st dose) outcome was unknown and PAIN IN EXTREMITY (Arm soreness) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient used Mometasone Furoate cream by the dermatologist but it did not work for her as treatment.   This case was linked to MOD-2021-384243, MOD-2021-384200, MOD-2021-384243 (Patient Link).
Headache, Nausea, diarrhea, arm swollen at injection site. wrist swollen, backache, swollen Lymph nodes, body aches, swollen wrist.
Patient had his 2nd Men B shot 6/17/21 around 11am and later that night he reported developing a fever, chills, and nausea. These symptoms continued into today 6/18/21. Patient was seen by provider and PCR for covid was done as well as an evaluation by the doctor. patient left with his mother and denies anymore symptoms at this time. Patient is at home and agrees to call with any new or worsening symptoms.
Patient came in for Flu vaccine, Right and TDAP, Left. Complaint of pain and swelling next day- c/o very painful. Called PMD today-appointment made for 5/7/09 at 8:30/AM.
her regular non-genital warts have cleared up, off of her hands; This spontaneous report was received from a physician who was the female patient of unknown age, via a company representative, reporting on herself. Information regarding the patient's pertinent medical history, concomitant and historical drugs was not provided. The patient's concurrent conditions included non-genital wart.  On an unknown date, the patient was self-vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (dose, route, anatomical location, lot # and expiration date were not provided) for Human Papillomavirus (HPV) prophylaxis. On an unknown date, the physician reported that her "regular" non-genital warts had "cleared up, off of her hands".
All I remember is I was holding my work sign and next thing I know I was on my knees I had passed out, I had a n incredible headachew.I was driven to ER room. Tests were ran
Mom states that the pt has swelling in the right leg to twice the normal size with redness. No defined lump at this time. No fever or pain. The child is playing with no complaints. As of 1/31/01 the symptoms are resolving with no fever or pain.
flu-like sx, sore, swollen throat, fatigue, fever & h/a fro 5 days, rash over body- 1 day,, lump on neck & armpits 1-3 days; itching red spots on face w/swelling;
Pt recv vax on 10/26/98; on 10/27/98 pt exp flushing, fever, chills, vax site pain/red/swelling, pain left axilla; tx=Benadryl
Nausea, body aches and chills for 24 hrs, no fever did not present for evaluation.
Under-age administration of Pfizer vaccine (11 years old, Pfizer EUA approved only for 12-17yo minors).  Error discovered AFTER VACCINATION when data entry of DOB was BLOCKED by system for DOB ERROR. Signs and symptoms: None Diagnosis and treatment: Patient accompanied by parent. Patient observed for 15 minutes per CDC protocol, no adverse reaction observed. Patient released from mobile vaccination clinic in unremarkable, stable condition around 11 AM. No treatment required. Diagnosis: vaccine error related to age of minor child. Supervisor reported event to site manager RN for VAERS reporting.
Patient received vaccine after published expiration date. Moderna Company analyzed lot 007B21A and advised  vaccine maintained  activity necessary to protect against covid 19 at date of administration. Also patient did not call in to report adverse event.  This is administration error without adverse event.
This spontaneous report has been received from a pharmacist referring to a patient of unknown age and gender. Information regarding the patient's medical history, drug reactions or allergies, and concurrent conditions was not reported. Concomitant therapies included sterile diluent. On 13-MAR-2018, the patient was vaccinated with (wistar ra 27-3) M-M-R II lot # N020923, with expiration date of 01-AUG-2019, by intramuscular route, (strength, dose and anatomical location was not provided) for prophylaxis (incorrect route of drug administration). No adverse events were reported.
Employee received first dose of MMR vaccine and Varicella vaccine based on negative titer results. After waiting in the office for a period of time the RN asked if he felt fine to leave and he stated yes. About 30 minutes after he left, he called and said he felt tightness in his back and it was hard to swallow. The nurse directed him straight to the Emergency Department. Employee stated he was treated with an EPIPEN and given oral ZYRTEC and Prednisone.
Case number PHHY2011US43961 is an initial spontaneous report received from a nurse on 19 May 2011 with a combined follow up report received from nurse on 01 Jun 2011 and 07 Jun 2011. This report refers to a 19 year old female patient. She was given only the CYW-135 liquid component of MENVEO vaccine (batch number 091201, expiry date: Sep 2012) intramuscularly in the right arm deltoid on 26 Nov 2010. She came back alter and received the full dose. No other adverse reaction was reported. Combined follow up information received on 01 Jun 2011 and 07 Jun 2011: Further vaccination details were provided.
after her second shot when she was feeling discomfort an 1 or 2 after the shot; This is a spontaneous report from a contactable consumer reporting for his wife. A 76-years-old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 2ND DOSE, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced "feeling discomfort an 1 or 2 after the shot" on an unspecified date with outcome of unknown. Therapeutic measures were taken ibuprofen. No follow-up attempts are possible; information about lot/batch number cannot be obtained
F/u visit 5/11/05, 24hrs.after vaccine .administered.  Pt.presented w/localized reaction to injection,left thigh (6"x3.5")red,raised erythematous area, hot to touch, area hard when palpated. pt. c/o pain w/ ambulation.  Doctor after assessment prescribed Prelone, 15mg/5ml, 1 tsp po bid x 5 days, dispensed 60 ml., and Benadryl 12.5 mg, 1 tsp po bid prn-dispense 60 ml.  Mother educated on adverse rxns and verbalized understanding of follow up treatment.  Will phone if any change in symptoms or will call 911 if s/s of respiratory distress.
Patient received 1st Moderna Vaccine 3/5/21  and the second vaccine has not been administered
I started to get Migraines the day of the shot. I was nauseous and I did have seizure which only happens twice a year. My seizures are not always triggered by migraine. I have a history of hives and I get reactions to bites. I decided to get the Johnson & Johnson because it seemed to be a better option. Ten days after the vaccine I had a Migraine that was so bad I had to go to the doctor. When I got there my blood pressure was high. I was given some migraine medicine, but it did not help. The migraine was there for four weeks after the shot. I still got a numbing headache after the shot until five weeks after the shot.
Information has been received from a licensed practical nurse (LPN) concerning an adult patient who was vaccinated IM with a 0.5 mL dose of Pneumovax 23 (lot #655288/1174F).  Subsequently, within 24 hours, the patient developed swelling, redness and pain at the injection site.  The patient sought unspecified medical attention.  On an unspecified date, the patient recovered.  Additional information has been requested.
I have rashes on my face like rashes. They appeared few days after the first dose but is yet to clear.
tested positive for COVID 13Mar2021; This is a spontaneous report from a contactable consumer (patient) via the Pfizer-sponsored program COVAX US Support. A 23-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular, administered in Arm Left on 05Mar2021 (Batch/Lot Number: EN6199; Expiration Date: 30Jun2021) as 1ST DOSE, SINGLE for covid-19 immunisation (Age at vaccination: 23 years). Medical history included hypoglycaemia from Jul2019 and ongoing. There were no concomitant medications. The patient stated that she had tested positive for COVID on 13Mar2021. The patient underwent lab tests and procedures which included Covid-19 Test: negative on 11Mar2021 and Covid-19 Test: positive on 13Mar2021. The event was reported as non-serious by the reporter. Outcome of the event was unknown.
5AUG92 dad states pt ran t103; 31JUL took to ER seen by MD who gave APAP; pt had UTI;
Breakthrough case admission after 2 vaccines Pfizer 7/8/21 lot# EW0186;  Pfizer 8/5/21 lot# Ew0181
Faint/loss of conciousness 5 minutes after shot.  Gastrointestinal issues 1 hour after shot.  Headache/vomiting 3 hours after shot.
Vax given 1130AM, apnea monitor went off @ 6PM & again later; Pt breathed on own each time; 2nd time pt taken to ER & kept overnight;
MENINGITIS; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, 1 total start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date after receiving COVID-19 vaccine, the patient developed meningitis.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of meningitis was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0;20210420512-covid-19 vaccine ad26.cov2. s-meningitis. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
TRANSIENT ISCHAEMIC ATTACK; BLINDNESS UNILATERAL; VISION BLURRED; COMPUTERISED TOMOGRAM HEAD; ECHOCARDIOGRAM; MAGNETIC RESONANCE IMAGING HEAD; ULTRASOUND DOPPLER; This spontaneous report received from a patient via a Regulatory Authority Vaccine Adverse Event Reporting System (VAERS) (VAER reference number 1231357) concerned a 79 year old female of unknown race and ethnicity. The patient's height, and weight were not reported. The patient's past medical history included congestive heart failure, and atrial fibrillation, and concurrent conditions included diabetes, and other pre-existing medical conditions included patient has no allergy or illness. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802070, expiry: UNKNOWN) dose was not reported, 1 total, administered on left arm on 08-MAR-2021 for prophylactic vaccination. Concomitant medications included ergocalciferol, magnesium, and mecobalamin. On 06-APR-2021, the patient woke up with lost of vision in left eye for 4 to 5 hours. Patient went to her ophthalmologist; the sight came back but very blurry. Retina specialist had seen patient on 13-APR-2021 and diagnosed transient ischaemic attack of left eye. The patient was guided to go to ER on 13-APR-2021. On 06-APR-2021, the patient experienced blindness unilateral, vision blurred. The patient was admitted in the hospital on 13-APR-2021 and was hospitalized for 3 days. Laboratory data included: Computerized tomogram head (NR: not provided) UNKNOWN, Echocardiogram (NR: not provided) UNKNOWN, Magnetic resonance imaging head (NR: not provided) UNKNOWN, and Ultrasound Doppler (NR: not provided) UNKNOWN. Laboratory data (dates unspecified) included: Eye exam (NR: not provided) Unknown. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from blindness unilateral, transient ischaemic attack, vision blurred, computerised tomogram head, echocardiogram, magnetic resonance imaging head, and ultrasound doppler. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20210500771 - Covid-19 vaccine ad26.cov2.s- blindness unilateral, transient ischaemic attack, vision blurred, computerised tomogram head, echocardiogram, magnetic resonance imaging head, and ultrasound doppler. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
I'm having problem with my eyes; it comes and goes. I have random twitching on my right and left eye. It never happens.  Once my left eye starts to twitch, it could be consistent, and my right eye, quivers at the bottom of my eye. I thought it could be a magnesium deficiency. I worried that it could be neurological. I've been dealing with it since April. It kept doing it every day and I cut caffeine and I thought it could be that. I tried sleeping more. Its random with no trigger. I have a lot of allergies in my family, and I thought it could be an allergy. I saw Dr for my issue, it was sometime in the summer. They sent me to a neurologist, I don't remember the name, but my test came back normal.
"Almost collapsed"; "Severe muscle aches"; The whole weakness thing"; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA ("The whole weakness thing" "Almost collapsed") and MYALGIA ("Severe muscle aches") in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced ASTHENIA ("The whole weakness thing" "Almost collapsed") and MYALGIA ("Severe muscle aches"). At the time of the report, MYALGIA ("Severe muscle aches") outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided.  No treatment medications were provided. This case was linked to MOD21-091684, MOD21-091689, INC.-MOD-2021-143088 (E2B Linked Report). This case was linked to MOD-2021-142497 (Patient Link).; Sender's Comments: MOD21-091684:crosslinked, MOD21-091689:crosslinked, INC.-MOD-2021-143088:Crosslink
Back pain; Headache; Some nausea; Fever; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Back pain), HEADACHE (Headache), NAUSEA (Some nausea) and PYREXIA (Fever) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 052C21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 08-May-2021.    On 22-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jul-2021, the patient experienced BACK PAIN (Back pain), HEADACHE (Headache), NAUSEA (Some nausea) and PYREXIA (Fever). At the time of the report, BACK PAIN (Back pain), HEADACHE (Headache), NAUSEA (Some nausea) and PYREXIA (Fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jul-2021, Body temperature: 102 degrees High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medication was received by the patient No Treatment was received by the patient.
Discharge Provider:  Primary Care Provider:  MD Admission Date: 3/28/2023 Discharge Date: Apr 5, 2023  PRESENTING PROBLEM: Acute respiratory failure (HCC)  Hypoxia  COVID-19  Acute respiratory failure with hypoxia and hypercapnia (HCC)    HOSPITAL COURSE: DETAILS OF HOSPITAL STAY:   HOSPITAL COURSE: Patient is a 65-year-old male with history of paroxysmal atrial fibrillation, peripheral arterial disease, hyperlipidemia, chronic pain, depression and COPD who presented with 1 week history of increasing shortness of breath, cough, sputum production.  Due to increasing shortness of breath, he called EMS.  EMS found him to have oxygen saturation of 60% on room air, and placed him on a non-rebreather mask.  He was given DuoNebs, albuterol and IV Solu-Medrol en route.  Upon arrival to the emergency department, he was tachycardic in transition to BiPAP therapy with FiO2 of 0.80.  He had an initial venous blood gas with a pCO2 of 72 and a pH of 7.22.  Labs showed a WBC count of 12.1.  Chest x-ray was unremarkable.  He was continued on DuoNeb therapy in the emergency department, as well as BiPAP therapy, and admitted to the hospitalist service to the intensive care unit.   Upon admission, the patient was continued on BiPAP therapy, IV Solu-Medrol and scheduled DuoNebs.  He was started on remdesivir.  Within 24 hours, he was able to be weaned off of BiPAP during the day, and placed on 3 L of oxygen via nasal cannula.  After 48 hours, he was able to be transferred out of the intensive care unit.  He continued to require BiPAP therapy at night, and was noted to have increasing WBC count and purulent sputum production on 3/31.  He was empirically started on IV cefepime and oral doxycycline for suspected superimposed bacterial pneumonia.  Sputum culture was collected, and remained without growth.  He was seen by Physical and Occupational therapy, who recommended inpatient rehabilitation facility, however subsequent evaluations were consistent with home with assist.   Patient had to moved back to intensive care unit least respiratory distress needing BiPAP pulmonary was involved.  Pulmonary rehab was consulted for arrangement of home BiPAP and this was able to be authorized and arranged.  Patient gradually improved on supportive treatment with antibiotics, steroid taper and bronchodilators and was able to be transitioned off the general floor.    When steroid induced hyperglycemia, patient was given 10 days of metformin.  He will finish 7 day course of antibiotics, Ceftin and doxycycline was given
after injection pt has redness and a lump under the skin which has taken about 3 days to start getting better.
Blood disorder; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD DISORDER (Blood disorder) in a 43-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Dec-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BLOOD DISORDER (Blood disorder). At the time of the report, BLOOD DISORDER (Blood disorder) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant use were reported No Treatment were reported
dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness) in an 85-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. ASKU) for COVID-19 prophylaxis.     The patient had no allergies.  Concurrent medical conditions included Parkinsonism (Deep brain stimulator for Parkinsonism), Atrial fibrillation (Pacemaker for atrial fibrillation) and Arthritis. Concomitant products included PARACETAMOL (TYLENOL), CORTISONE from 14-Nov-2022 to an unknown date and INFLUENZA VACCINE from 27-Oct-2022 to an unknown date for an unknown indication.    On 30-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 01-Dec-2022,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced DIZZINESS (dizziness). At the time of the report, DIZZINESS (dizziness) had not resolved.            The patient received Moderna primary series dose 1 on 24-Mar-2021 (lot number 016B21A) and dose 2 on 21-Apr-2021 (lot number 048B21A). Moderna booster on 16-Nov-2021 (lot number 034F21A) and 29-Jun-2022 (lot number 058A22-2A). It was reported that, the patient got her bivalent booster on 30-Nov-2022 and the dizziness started on 01-Dec-2022. It had been a week. The patient took Tylenol regularly. They were trying to push fluids. The patient got cortisone gel injections in both knees on 14-Nov-2022. She got a flu vaccine on 27-Oct-2022.  No treatment details were reported.
1/6/09 - Vaccine administered. 1/19/09 - Developed severe viral symptoms. 1/25/09 - Dx with DVT and hospitalized; put on Heparin. 1/27/09 - D/C on Lovanox inj and Coumadin.  2/26/09-records received-for DOS 1/26-1/27/09-DC DX: Left lower extremity deep vein thrombosis in left mid superficial femoral vein to popliteal vein. Possible infectious mononucleosis versus cytomegalovirus (acute). Elevated liver function tests. Presented with 3 day history of left lower extremity pain
Two days after receiving the vaccine, I developed extreme pressure in sinuses without significant nasal drip. I developed headaches along with this sinus pressure and developed flashes in my eyesight. Off and on migraines since vaccination, off and on sinus pressure but continued flashes in vision in the right eye more than the left.